Skip to content
OpenCapital
Get started

AngioDynamics ANGO Debt-to-equity

Debt-to-equity at other companies

Abbott logo
AbbottABT
0.7×+0.4×
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
0.6×-0.1×
TFX
TeleflexTFX
0.9×+0.4×
Merit Medical Systems logo
Merit Medical SystemsMMSI
0.5×-0.1×
ICU Medical logo
ICU MedicalICUI
0.6×-0.2×
Boston Scientific logo
Boston ScientificBSX
0×-0.5×

Other financials

Income statement

See full
Revenue$78.4M+8.9%
Gross profit$41.5M+6.7%
Operating income-$13.0M-29.8%
Net income-$8.1M-83.4%
EPS (diluted)-$0.19-72.7%

Balance sheet

See full
Cash & equivalents$37.8M-15.5%
Total debt$7.9M+10.2%
Total equity$173.4M-6.7%
Total assets$260.7M-8.7%

Cash flow

See full
Operating cash flow-$3.1M+76.4%
CapEx$1.0M-43.5%
Free cash flow-$4.1M+72.4%

Valuation

See full
Market cap$564.42M+38.7%
Enterprise value$534.51M+48.0%
P/S1.8×+0.4×

Profitability

See full
Gross margin54.3%-0.1pp
Operating margin-11.3%-2.9pp
Net margin-10%-2.4pp
FCF margin5.5%—

Returns & leverage

See full
Return on equity-17.5%-2.2pp
Current ratio2.4×+0.1×

Where this comes from

Calculated from AngioDynamics’s reported figures.

total debt/total stockholders equity=0×

Based on the most recent quarter.

The official record: AngioDynamics’s 10-Q, filed April 2, 2026, on SEC EDGAR. View the filing →

Ask your AI about AngioDynamics's debt-to-equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AngioDynamics's debt-to-equity?
AngioDynamics (ANGO) reported debt-to-equity of 0× in Q4 2025.
How has AngioDynamics's debt-to-equity changed year-over-year?
AngioDynamics's debt-to-equity increased by 18.1% year-over-year, from 0× to 0×.
What is the long-term trend for AngioDynamics's debt-to-equity?
Over 4 years (2021 to 2025), AngioDynamics's debt-to-equity has grown at a 25.7% compound annual growth rate (CAGR), from 0× to 0.1×.
What does debt-to-equity mean?
Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.